Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point‐of‐care-Reference-Cited by-同舟云学术

Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point‐of‐care

Published:2021-11-17 Issue:2 Volume:42 Page:309-319
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Valencia Jorge¹²^ORCID,Lazarus Jeffrey V.³⁴^ORCID,Ceballos Francisco C.⁵^ORCID,Troya Jesús¹^ORCID,Cuevas Guillermo¹^ORCID,Resino Salvador⁵^ORCID,Torres‐Macho Juan¹,Ryan Pablo¹⁶⁷^ORCID

Affiliation:

1. Internal Medicine Service University Hospital Infanta Leonor Madrid Spain

2. Harm Reduction Unit ‘SMASD’ Addictions and Mental Health Department Madrid Spain

3. Barcelona Institute for Global Health (ISGlobal) Hospital Clínic University of Barcelona Barcelona Spain

4. Faculty of Medicine University of Barcelona Barcelona Spain

5. Viral Infection and Immunity Unit National Centre for Microbiology Health Institute Carlos III Madrid Spain

6. School of Medicine Complutense University of Madrid Madrid Spain

7. Gregorio Marañón Health Research Institute Madrid Spain

Funder

Gilead Sciences

Instituto de Salud Carlos III

AbbVie

Asociación Española para el Estudio del Hígado

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15095

Reference52 articles.

1. World Health Organization.Global Progress Report on HIV Viral Hepatitis and Sexually Transmitted Infections. Accountability for the Global Health Sector Strategies 2016–2021: Actions for Impact.Switzerland;2021.

2. HCV screening based on dried blood samples and linkage to care in people who use drugs: A prospective study

3. Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysis

4. Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review

5. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peer-Assisted Telemedicine for Hepatitis C (PATHS): Process evaluation results from a State Opioid Response-funded program;Journal of Substance Use and Addiction Treatment;2024-12

2. Hazardous Alcohol Use and Its Effect on Direct-Acting Antiviral Therapy Initiation among People with Active Injection Drug Use and Current Hepatitis C Infection;Viruses;2024-09-05

3. Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA‐C);Drug and Alcohol Review;2024-08-02

4. Viral hepatitis testing and treatment in community pharmacies: a systematic review and meta-analysis;eClinicalMedicine;2024-03

5. Hepatitis C screening and linkage to care with a mobile clinic in Southern Denmark;International Journal of Drug Policy;2023-11